NFE2L2 and neoplasm: After being treated with Ara-C, the tumor size of the Nrf2 overexpressed groups was not sufficiently inhibited compared with the EV groups (P < 0.05, Fig. 6C, D), and overexpressing Nrf2 of mice had shorter survival times (P < 0.05, Fig. 6E).